Response to: Prognosis of metastatic bone cancer and myeloma patients and long‑term risk of medication‑related osteonecrosis of the jaw (MRONJ): some critical points.
Hironobu HataKenji ImamachiMichihiro UedaMasashi MatsuzakaHiroaki HiragaToshihisa OsanaiToru HarabayashiKatsuya FujimotoSatoshi OizumiMasato TakahashiKazuhito YoshikawaJun SatoYutaka YamazakiYoshimasa KitagawaPublished in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer (2022)